Evidence for a relationship between plasminogen activator inhibitor-1 and gamma glutamyl transferase
- 15 January 1996
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 81 (2) , 271-275
- https://doi.org/10.1016/0049-3848(95)00244-8
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.Circulation, 1994
- Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases.Journal of Clinical Pathology, 1994
- Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic menDiabetologia, 1993
- The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistanceMetabolism, 1993
- Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.Journal of Clinical Investigation, 1993
- Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosisDiabetologia, 1991
- Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factorsHepatology, 1990
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987